The association between postoperative recurrence and expression of PD-L1, but not PD-1, supports the effect of PD-L1 in regeneration of HCC cells as an inhibitor of antigen presentation via PD-L1–CD80 axis (19). This evidence concerns the gene CD80 and hepatocellular carcinoma.